Antivaccine lobby resists introduction of Hib vaccine in IndiaBMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c3508 (Published 29 June 2010) Cite this as: BMJ 2010;340:c3508
- Ganapati Mudur
A campaign against the Haemophilus influenzae type b (Hib) vaccine in India launched by some medical professionals has delayed a government plan to introduce the vaccine through its free national immunisation programme for children.
The health ministry had last year announced that it would replace the standard vaccine for diphtheria, pertussis, and tetanus with a pentavalent vaccine that would also protect children against hepatitis B and Hib.
The Global Alliance for Vaccines and Immunisation (GAVI), after consultation with the Indian health ministry, had pledged in August 2009 a grant of $165m (£110m; €135m) to roll out the new vaccine to cover 10 million children in 10 of India’s 28 states in 2010.
The Hib organism, which can cause severe bacterial meningitis and pneumonia, is estimated to kill more than 370 000 children worldwide each year, GAVI said. Nearly 20% of these deaths occur in India.
But the campaign mounted against the Hib vaccine …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.